Study of a new injection for early hip arthritis
Part of Bones, joints & muscles clinical trials.
This study tests a new treatment called TG-C, which is an injection into the hip joint designed to help repair early cartilage damage and reduce pain. If you have early osteoarthritis in your hip and are looking for a non-surgical option, this might be a chance to try an experimental therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with early-stage osteoarthritis in one hip (not the most severe grade).
- You have at least moderate hip pain (40 or higher on a 0–100 scale) and groin pain triggered by hip movement.
- Your body mass index (BMI) is under 40, and your blood pressure is in a normal range.
- You are not taking certain pain medications (like steroids or NSAIDs) within 14 days of starting the study.
- You have not had surgery or injections in the affected hip recently (within 6 months or 3 months, respectively).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This trial tests a combination of a steroid and lubricant injection into the hip joint plus physical therapy to treat mild hip arthritis or related issues like a labral tear. It aims to see if this approach can reduce pain and improve function without surgery.
This study tests an experimental injection called GNSC-001 given directly into the knee to see if it can reduce pain and improve knee function in people with knee osteoarthritis. If you join, you'll have one injection and then be followed for a year, and you'll need to stop your usual knee pain medicines during the study.
This trial compares a “bone marrow aspirate concentrate” injection with a corticosteroid (steroid) injection to reduce pain from hip osteoarthritis. It aims to see which treatment works better over time for hip pain and function.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
Hear when a new Degenerative Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.